TARGETED THERAPY IN THE TREATMENT OF PATIENTS METASTATIC COLORECTAL CANCER

NIYOZOVA Shakhnoza Khamoydinovna, KAMISHOV Sergey Viktorovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2022-yil

Annotatsiya

Objective: to study the possibilities of targeted therapy in patients with metastatic colorectal cancer (CRC). Methods: three groups of 75 CRC patients with liver metastases received standard chemotherapy regimens (CT) XELOX and FOLFOX4; in the experimental groups, the treatment regimens included targeted drugs bevacizumab and cetuximab. Results: the addition of targeted drugs to the treatment regimens for patients with metastatic CRC significantly increased both the overall survival of patients and increased the time for the appearance of signs of disease progression. The median follow-up was 42.3 months. At the same time, the best results were shown by the treatment regimen, including preoperative CT according to the XELOX / FOLFOX4 + bevacizumab regimens, the targeted drug cetuximab showed less results. Conclusions. In our study, the inclusion of targeted drugs in conventional CT regimens significantly improved the effectiveness of treatment in patients with metastatic CRC. At the same time, the treatment regimen that included preoperative CT with the addition of the targeted drug bevacizumab showed the best results.

Maqola ma’lumotlari
MualliflarNIYOZOVA Shakhnoza Khamoydinovna, KAMISHOV Sergey Viktorovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2022-09-05
Jild7
Son4
TilRus

Kalit so‘zlar

колоректальный рак, метастазы, таргетные препараты, химиотерапия, chemotherapy, colorectal cancer, metastases, targeted drugs, yo'g'on ichak saratoni, metastazlar, maqsadli dorilar, kimyoterapiya

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar